查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2109227

2026 年至 2035 年標準化植物萃取物製造市場的商業機會、成長要素、產業趨勢和預測。

Standardized Plant Extract Manufacturing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球標準化植物萃取物製造市場預計到 2025 年價值 196 億美元，年複合成長率為 7.6%，到 ​​2035 年將達到 402 億美元。

標準化植物萃取物製造市場-IMG1

標準化植物萃取物製造業的強勁發展勢頭持續強勁，這主要得益於以下因素：在既定監管框架內，植物來源活性藥物成分 (API) 的應用日益廣泛；全球對醫療保健的關注度不斷提高，推動了膳食補充劑消費量的成長；以及食品、飲料和化妝品行業對「潔淨標示」要求的日益嚴格，進而影響了原料的採購。超臨界二氧化碳萃取和酵素法加工等萃取技術的不斷進步，使製造商能夠提供以往難以透過傳統方法獲得的高純度藥用級萃取物，同時提高了生產效率。隨著法律規範不斷鼓勵將標準化植物成分整合到藥物研發中，對植物藥和植物來源API 的需求不斷成長，進一步推動了市場擴張。同時，製造商正透過人工智慧驅動的生物活性篩檢技術和基於區塊鏈的批次追蹤系統來加強品質保證。這些數位創新增強了真實性驗證，最佳化了供應鏈透明度，支持了監管合規性，在生產前預測了生質能活性成分含量，提高了品質一致性，減少了原料浪費，並最大限度地降低了批次間的不合格率，使生產商能夠在提高運營效率的同時，提供滿足日益嚴格的客戶要求的標準化植物提取物。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 196億美元
預測金額 402億美元
複合年成長率 7.6%

預計到2025年，類黃酮和多酚類物質的銷售額將達到51億美元。由於其在營養保健品、藥品、機能性食品和化妝品配方中的廣泛應用，該類別仍然是最大的產品細分市場。市場參與企業正日益注重產品差異化，不僅在標準化濃度水平上競爭，還透過投資先進的配方技術來提高成分的吸收率、生物利用度、穩定性和性能。這項策略使製造商能夠在保持高價位的同時提供更高附加價值的產品，從而增強其在全球標準化植物萃取物生產市場的競爭力。

營養保健品和膳食補充劑應用領域佔35.8%的市場佔有率，預計到2025年市場規模將達到70億美元。該領域持續受益於消費者對預防性健康維護日益成長的偏好、對經臨床驗證的植物來源成分信心的增強以及線上膳食補充劑銷售管道的快速擴張。隨著各類健康產品類型對標準化植物萃取物的需求不斷成長，製造商持續研發功效檢驗、品質穩定且具有科學依據的配方。這些因素使得原料供應商能夠在滿足消費者對可靠植物來源產品不斷變化的期望的同時，維持較高的定價。

預計到2025年，北美標準化植物萃取物生產市場規模將達到53億美元，並在2035年之前以7.1%的複合年成長率成長。美國仍然是該地區最大的銷售貢獻者，這得益於其全球最大的膳食補充劑產業以及完善的成分標籤和行銷法規環境。日益嚴格的產品功效法律規範促使製造商和配方研發人員採用檢驗的分析標準支持的標準化植物成分，從而在製藥、營養保健品和消費者健康領域創造了對高品質植物萃取物的持續需求。

全球標準化植物萃取物生產市場的主要參與者包括：Indiana SpA、奇華頓公司（包括Naturex）、Sabinsa Corporation、Martin Bauer Group、Layn Natural Ingredients Corp.、Euromed SA、Arjuna Natural Ltd.、PLT Health Solutions、Star Hi Herbs Pvt. Ltd.、晨光生物科技Group Limited、永明生物科技有限公司、永明生物科技有限公司Inc.、Synthite Industries Ltd.和Nexira SAS。這些企業正透過優先投資於先進的萃取技術、品質保證體系和產品創新來鞏固其市場地位。許多製造商正在擴大產能，同時實施自動化加工、數位化品質監控和可追溯性解決方案，以提高產品的一致性和合規性。此外，每家公司都致力於開發高功能性、高純度的標準化萃取物，以滿足製藥、營養保健品、食品、飲料和個人護理產品製造商不斷變化的需求。與原料供應商、契約製造和研究機構建立策略合作夥伴關係，有助於確保可靠的採購，並加速產品開發。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
    • 產業潛在風險與挑戰
    • 市場機遇
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 價格趨勢
    • 按地區
    • 依活性成分/化合物類型
  • 未來市場趨勢
  • 專利趨勢
  • 貿易統計
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 具有環保意識的舉措

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • LATAM
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依活性成分/化合物類型分類，2022-2035年

  • 黃酮類化合物和多酚類化合物
  • 生物鹼
  • Terpenoids和皂素
  • 類胡蘿蔔素
  • 單寧和酚酸
  • 配糖體
  • 其他

第6章 市場估算與預測：依萃取技術分類，2022-2035年

  • 溶劑萃取
  • 超臨界二氧化碳萃取
  • 水基萃取
  • 酵素提取
  • 利用層析法進行分離純化
  • 其他

第7章 市場估計與預測：依應用領域分類，2022-2035年

  • 藥品和草藥
  • 營養保健品和膳食補充劑
  • 食品/飲料
  • 化妝品和個人護理
  • 動物營養與獸醫學
  • 農業用途

第8章 市場估算與預測：依生產類型分類，2022-2035年

  • 乾燥粉末萃取物
  • 液體萃取物
  • 半固體

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第10章：公司簡介

  • Indena SpA
  • Givaudan SA（incl. Naturex）
  • Sabinsa Corporation
  • Martin Bauer Group
  • Layn Natural Ingredients Corp.
  • Euromed SA
  • Arjuna Natural Ltd.
  • PLT Health Solutions
  • Star Hi Herbs Pvt. Ltd.
  • ChenGuang Biotech Group Co., Ltd.
  • Specialty Natural Products Co., Ltd.（SNPS）
  • Inner Mongolia Ever Brilliance Biotechnology Co., Ltd.（KEB）
  • Organic Herb Inc.
  • Synthite Industries Ltd.
  • Nexira SAS
簡介目錄
Product Code: 16380

The Global Standardized Plant Extract Manufacturing Market was valued at USD 19.6 billion in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 40.2 billion by 2035.

Standardized Plant Extract Manufacturing Market - IMG1

Strong momentum across the standardized plant extract manufacturing industry continues to be fueled by the growing use of botanical active pharmaceutical ingredients (APIs) within established regulatory systems, expanding global interest in preventive healthcare, which supports higher nutraceutical consumption, and rising clean-label requirements that influence ingredient sourcing across the food, beverage, and cosmetics industries. Continuous advancements in extraction technologies, including supercritical CO2 and enzymatic processing, are also enabling manufacturers to supply high-purity, pharmaceutical-grade extracts that are difficult to achieve with conventional methods, while improving production efficiency. Increasing demand for phytopharmaceuticals and botanical APIs further supports market expansion as regulatory pathways continue to encourage the integration of standardized botanical ingredients into pharmaceutical development. At the same time, manufacturers are strengthening quality assurance through AI-powered bioactivity screening technologies and blockchain-enabled batch traceability. These digital innovations enhance authentication, optimize supply chain transparency, support regulatory compliance, predict biomass potency before production, improve quality consistency, reduce material losses, and minimize batch rejection rates, enabling producers to improve operational efficiency while delivering standardized botanical extracts that meet increasingly stringent customer requirements.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$19.6 Billion
Forecast Value$40.2 Billion
CAGR7.6%

The flavonoids & polyphenols segment generated USD 5.1 billion in 2025. This category continues to represent the largest product segment because of its extensive utilization across nutraceuticals, pharmaceuticals, functional foods, and cosmetic formulations. Market participants are increasingly differentiating their offerings by investing in advanced formulation technologies that improve ingredient absorption, bioavailability, stability, and performance rather than competing solely through standardized concentration levels. This strategy enables manufacturers to deliver higher-value products while maintaining premium pricing and strengthening their competitive positioning within the global standardized plant extract manufacturing market.

The nutraceuticals and dietary supplements application segment accounted for a 35.8% share, generating USD 7 billion in 2025. The segment continues to benefit from growing consumer preference for preventive wellness, increasing confidence in clinically supported botanical ingredients, and the rapid expansion of online dietary supplement sales channels. Rising demand for standardized plant extracts across wellness-focused product categories continues to encourage manufacturers to develop formulations with verified potency, consistent quality, and scientifically supported efficacy. These factors are allowing ingredient suppliers to secure premium pricing while meeting evolving consumer expectations for reliable botanical products.

North America Standardized Plant Extract Manufacturing Market was valued at USD 5.3 billion in 2025 and is forecast to grow at a CAGR of 7.1% through 2035. The United States remains the largest contributor to regional revenue, supported by the world's largest dietary supplement industry and an established regulatory environment governing ingredient labeling and marketing practices. Increasing regulatory oversight surrounding product claims is encouraging manufacturers and formulators to rely on standardized botanical ingredients supported by validated analytical specifications, creating sustained demand for high-quality plant extracts across pharmaceutical, nutraceutical, and consumer health applications.

The major companies operating in the global standardized plant extract manufacturing market include Indena S.p.A., Givaudan SA (including Naturex), Sabinsa Corporation, Martin Bauer Group, Layn Natural Ingredients Corp., Euromed S.A., Arjuna Natural Ltd., PLT Health Solutions, Star Hi Herbs Pvt. Ltd., ChenGuang Biotech Group Co., Ltd., Specialty Natural Products Co., Ltd. (SNPS), Inner Mongolia Ever Brilliance Biotechnology Co., Ltd. (KEB), Organic Herb Inc., Synthite Industries Ltd., and Nexira SAS. Companies operating in the standardized plant extract manufacturing industry are strengthening their market position by prioritizing investments in advanced extraction technologies, quality assurance systems, and product innovation. Many manufacturers are expanding production capacity while adopting automated processing, digital quality monitoring, and traceability solutions to improve consistency and regulatory compliance. Businesses are also focusing on developing high-purity standardized extracts with enhanced functionality to address the evolving requirements of pharmaceutical, nutraceutical, food, beverage, and personal care manufacturers. Strategic partnerships with raw material suppliers, contract manufacturers, and research organizations help secure reliable sourcing and accelerate product development.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Active Constituent/Compound Type
    • 2.2.2 Extraction Technology
    • 2.2.3 Application
    • 2.2.4 Output Form
    • 2.2.5 Regional
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
  • 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Technology and innovation landscape
    • 3.7.1 Current technological trends
    • 3.7.2 Emerging technologies
  • 3.8 Price trends
    • 3.8.1 By region
    • 3.8.2 By Active Constituent/Compound Type
  • 3.9 Future market trends
  • 3.10 Patent landscape
  • 3.11 Trade statistics (HS code)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Active Constituent/Compound Type, 2022–2035 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Flavonoids & Polyphenols
  • 5.3 Alkaloids
  • 5.4 Terpenoids & Saponins
  • 5.5 Carotenoids
  • 5.6 Tannins & Phenolic Acids
  • 5.7 Glycosides
  • 5.8 Others

Chapter 6 Market Estimates and Forecast, By Extraction Technology, 2022–2035 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Solvent Extraction
  • 6.3 Supercritical CO₂ Extraction
  • 6.4 Aqueous/Water-Based Extraction
  • 6.5 Enzymatic Extraction
  • 6.6 Chromatography-Based Separation & Purification
  • 6.7 Others

Chapter 7 Market Estimates and Forecast, By Application, 2022–2035 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 Pharmaceuticals & Botanical Drugs
  • 7.3 Nutraceuticals & Dietary Supplements
  • 7.4 Food & Beverages
  • 7.5 Cosmetics & Personal Care
  • 7.6 Animal Nutrition & Veterinary
  • 7.7 Agricultural Applications

Chapter 8 Market Estimates and Forecast, By Output Form, 2022–2035 (USD Million) (Kilo Tons)

  • 8.1 Key trends
  • 8.2 Dry Powder Extract
  • 8.3 Liquid Extract
  • 8.4 Semi-Solid

Chapter 9 Market Estimates and Forecast, By Region, 2022–2035 (USD Million) (Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Indena S.p.A.
  • 10.2 Givaudan SA (incl. Naturex)
  • 10.3 Sabinsa Corporation
  • 10.4 Martin Bauer Group
  • 10.5 Layn Natural Ingredients Corp.
  • 10.6 Euromed S.A.
  • 10.7 Arjuna Natural Ltd.
  • 10.8 PLT Health Solutions
  • 10.9 Star Hi Herbs Pvt. Ltd.
  • 10.10 ChenGuang Biotech Group Co., Ltd.
  • 10.11 Specialty Natural Products Co., Ltd. (SNPS)
  • 10.12 Inner Mongolia Ever Brilliance Biotechnology Co., Ltd. (KEB)
  • 10.13 Organic Herb Inc.
  • 10.14 Synthite Industries Ltd.
  • 10.15 Nexira SAS